Journals / Dicle Tıp Dergisi / 2014 / Cilt: 41 - Sayı: 1

The investigation of complete blood counting parameters in deep venous thrombosis

Derin ven trombozunda tam kan sayımı parametrelerinin araştırılması

Pages
118–122
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There is no significant change shown.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The role of inflammation in the deep venous thrombosis (DVT) process has been explained in various studies.
📊
Key Findings & Data:Methods: 50 patients admitted to our clinic with the diagnosis of acute DVT (28 female, 22 male) were included in the study.
💡
Conclusion & Impact:There is no significant change shown.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: The role of inflammation in the deep venous thrombosis (DVT) process has been explained in various studies. Hence, the role of inflammatory markers in this illness has been researched previouslyin the literature. Recent years, such as parameters, neutrophil lymphocyte ratio (NLR) and platelet lymphocyte ratio (PLR), among complete blood count have been frequently started to use as an expression of inflammatory marker. In the current study, the relation between complete blood count parameters and DVT was investigated. Methods: 50 patients admitted to our clinic with the diagnosis of acute DVT (28 female, 22 male) were included in the study. The patients were diagnosed by clinical symptoms and Doppler USG. Patients with additional illness that can form an inflammatory response were excluded. 30 healthy volunteers were included as a control group. Routine complete blood counts of these patients were examined retrospectively. Routine complete blood counts and nonselective inflammatory markers, red cell distribution width (RDW), white cells (WBC), NLR, and PLR measurements were examined statistically. Results: The mean age of patients included in study was 46.2±14.2 and 53% of them were female. When the groups were examined in terms of hematological parameters, lymphocyte (2.6±0.8 and 2.1±0.7, p=0.003) and platelet (322±144 and 264±66, p=0.042) values were detected to be higher. Hemoglobin (13.2±2.0 and 14.6±1.5, p=0.002) and hematocrit (38.7±5.1 and 42.8±6.9, p<0.001) values were detected to be less while the WBC, neutrophil, NLR, RDW and PLR were similar. Regarding the two groups with and without anticoagulant therapy, in the DVT group, there were no significant differences detected in terms of age, gender, and hematological parameters. Conclusion: In this study, there were no significant differences between healthy volunteers blood count parameters of patients taken into consideration with pure DVT. There is no significant change shown.

Özet

Amaç: Derin ven trombozunun (DVT) seyrinde inflamasyonun rolü çeşitli çalışmalarda açıklanmıştır. Bu nedenle literatürde inflamatuar belirteçlerin bu hastalıkta rolü araş- tırılmıştır. Son dönemde, tam kan sayımı parametreleri (Hemogram) arasında inflamatuar belirteçlerin kısa ifadesi olarak nötrofil lenfosit oranı (NLR), platelet lenfosit oranı (PLR) gibi belirteçler sıkça kullanılmaya başlanmıştır. Bu çalışma da hemogram parametrelerinin DVT ile ilişkisi incelenmiştir. Yöntemler: Kliniğimize akut DVT tanısı ile başvuran 50 hasta (28 kadın, 22 erkek) çalışmaya dahil edildi. Hastaların tanıları klinik semptomlar ve Doppler ultrasonografi ile konuldu. Hastalardan ek inflamatuar cevap oluşturacak hastalığı olanlar değerlendirme dışı bırakıldı. Kontrol grubu olarak da 30 sağlıklı gönüllü seçildi. Bu hastaların retrospektif olarak rutin hemogram sonuçları değerlendirildi. Rutin hemogram parametreleri ve nonselektif inflamatuar belirteçler olan kırmızı hücre dağılım hacmi (RDW), beyaz küre (WBC), NLR, PLR nin ölçümleri istatistiksel olarak incelendi. Bulgular: Çalışmaya alınan hastaların yaş ortalaması 46.2±14.2 yıl olup %53ü kadın cinsiyette idi. Gruplar hematolojik parametreler açısından incelendiğinde DVT grubunda lenfosit (2.6±0.8 ve 2.1±0.7, p=0.003) ve platelet miktarları (322±144 ve 264±66, p=0.042) daha yüksek, hemoglobin (13.2±2.0 ve 14.6±1.5, p=0.002) ve hematokrit değerleri (38.7±5.1 ve 42.8±6.9, p<0.001) daha düşük saptanırken, WBC, nötrofil, NLR, RDW ve PLR istatistiksel olarak benzer saptandı. DVT grubu antikoagülan alan ve almayan olarak iki gruba ayrıldığında yaş, cinsiyet ve hematolojik parametreler açısından gruplar arasında anlamlı farklılık izlenmedi Sonuç: Bu çalışmada değerlendirmeye alınan pür DVTli olgular ile sağlıklı gönüllülerin hemogram belirteçleri arasında anlamlı değişiklik göstermemiştir.

🔖

Cite This Article

ÇALIŞKAN, A., YAZICI, S., KARAHAN, O., DEMİRTAŞ, S., YAVUZ, C., GÜÇLÜ, O., TEZCAN, O., MAVİTAŞ, B. (2014). The investigation of complete blood counting parameters in deep venous thrombosis. Dicle Tıp Dergisi, Cilt: 41 - Sayı: 1, 118–122. https://ajindex.com/articles/349476

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Heit JA. Venouse thromboembolism: disease burden, outcomes and risk factors. J Thromb Haemost 2005;3:1611– 1617
  2. Nielsen JD. The incidence of pulmonary embolism during deep vein thrombosis. Phlebology 2013;28 Suppl 1:29-33
  3. Karabinos I, Koulouris S, Kranidis A, Pastromas S, Exadaktylos N, Kalofoutis A. Neutrophil count on admission predicts major in-hospital events in patients with a non-STsegment elevation acute coronary syndrome. Clin Cardiol 2009;32:561-568
  4. Reiter M, Bucek RA, Koca N, Dirisamer A, Minar E. Deep vein thrombosis and systemic inflammatory response: a pilot trial. Wien Klin Wochenschr 2003;115:111-114
  5. Bucek RA, Reiter M, Quehenberger P, Minar E. C-reactive protein in the diagnosis of deep vein thrombosis. Br J Haematol. 2002;119:385-389
  6. Culmer DL, Diaz JA, Hawley AE, et al. Circulating and vein wall P-selectin promote venous thrombogenesis during aging in a rodent model. Thromb Res 2013;131:42-8
  7. Roumen-Klappe EM, den Heijer M, van Uum SH, et al. Inflammatory response in the acute phase of deep vein thrombosis. J Vasc Surg 2002;35:701-706
  8. Wakefield TW, Strieter RW, Schaub R, et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy.Journal Of Vascular Surgery February 2000;31:309-324
  9. Bucek RA, Reiter M, Quehenberger P, et al. C-reactive protein in the diagnosis of deep vein thrombosis. Br J Haematol 2002;119:385-389
  10. Bhat T, Teli S, Rijal J et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther 2013;11:55-9
  11. Gary T, Pichler M, Belaj K, et al. Platelet-to-lymphocyte ratio: a novel marker for critical limb ischemia in peripheral arterial occlusive disease patients. PLoS One 2013;8:e67688 12. White RH. The epidemiology of venous thromboembolism. Circulation 2003;107:I4-8
  12. Lamping DL. Measuring health-related quality of life in venous disease: practical and scientific considerations. Angiology 1997;48:51-57
  13. Çırak Y, Savcı S, Karahan Z, et al. Akut derin ven trombozu sonrası yaşam kalitesi: VEINES-QOL/Sym ölçeğinin kültürel adaptasyonu, güvenirliği ve geçerliği: Türkçe versiyon çalışması. Turk Gogus Kalp Damar Cer Derg 2013;21:659-668 15. Wakefield TW, Henke PK. Erken ve geç venöz trombozda inflamasyonun rolü: Klinik anlamı var mı? Semin Vasc Surg 2005;18:118-129
  14. Brill A, FuchsTA, Savchenko AS, et al.Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost 2012;10:136–144